Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Mar 2007 17:10

Cyprotex PLC30 March 2007 Press Release 30 March 2007 Cyprotex PLC Director's Shareholding Name of Company CYPROTEX PLC Name of director ROBERT MORRISSON ATWATER 3. Please state whether notification indicates that it is in respect ofholding of the shareholder named in 2 above or in respect of a non-beneficialinterest or in the cast of an individual holder if it is a holding of thatperson's spouse or children under the age of 18 or in respect of anon-beneficial interest 2 ABOVE Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) ROBERT MORRISSON ATWATER Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) N/A Please sate the nature of the transaction. For PEP transactions please indicatewhether general/single co PEP and if discretionary / non discretionary MARKET PURCHASE Number of shares / amount of stock acquired 200,000 Percentage of issued class 0.14% Number of shares / amount of stock disposed N/A Percentage of issued class N/A Class of security ORDINARY SHARES OF 0.1 PENCE EACH Price per share 7.425 PENCE Date of transaction 30/3/2007 Date company informed 30/3/2007 Total holding following this notification 1,435,000 Total percentage holding of issued class following this notification 1.04% Any additional information N/A Name of contact and telephone number for queries MARK WARBURTON - 01625 505100 Name and signature of authorised company official responsible for making thisnotification MARK WARBURTON - COMPANY SECRETARY Date of Notification 30/3/2007 For further information: Cyprotex PLCRobert Morrison Atwater, CEOTel: +44 1625 505 100ir@cyprotex.comwww.cyprotex.com or Russell GibbsTel: +44 1625 505 100ir@cyprotex.comwww.cyprotex.com Media Enquires: WMC CommunicationsCharlie Geller/Alex GloverTel: +44 (0)20 7930 9030charlie.geller@wmccommunications.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Aug 20169:30 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
4th Aug 20169:37 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
4th Aug 20169:23 amRNSForm 8.3 - Cyprotex PLC
3rd Aug 201611:23 amBUSForm 8.3 - Cyprotex Plc
3rd Aug 20169:42 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
2nd Aug 20169:19 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
2nd Aug 20167:00 amRNSInterim Results
1st Aug 20169:32 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
29th Jul 20169:29 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
28th Jul 20169:54 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
27th Jul 20169:35 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
25th Jul 20169:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
22nd Jul 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
21st Jul 20169:56 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
20th Jul 201612:41 pmRNSTrading Update
19th Jul 20169:36 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
18th Jul 20169:32 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
15th Jul 20169:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
14th Jul 20169:33 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
12th Jul 201610:12 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th Jul 20169:38 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
7th Jul 20167:00 amRNSLaunch of New Advanced 3D Cardiotoxicity Model
6th Jul 201611:23 amRNSForm 8.3 - Cyprotex Plc
5th Jul 20163:17 pmRNSForm 8.3 - Cyprotex Plc
5th Jul 20169:36 amRNSForm 8.5 (EPT/RI)
4th Jul 20168:49 amRNSForm 8.5 (EPT/RI)
1st Jul 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
30th Jun 20169:53 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
29th Jun 20168:56 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
28th Jun 20169:09 amPRNForm 8.3 - Cyprotex
28th Jun 20169:02 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
27th Jun 20169:02 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
23rd Jun 201612:15 pmRNSResult of AGM
23rd Jun 20167:00 amRNSLaunch of New Endocrine Disruption Service
22nd Jun 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
21st Jun 201610:36 amRNSForm 8.5 (EPT/RI)
20th Jun 201610:56 amPRNForm 8.3 - Cyprotex Plc
16th Jun 20161:08 pmPRNForm 8.3 - Cyprotex plc
16th Jun 20167:00 amRNSLaunch of chemTarget
15th Jun 20169:03 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th Jun 20169:16 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
10th Jun 20168:50 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
9th Jun 20168:41 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
9th Jun 20167:00 amRNSPurchase of New IntelliCyt iQue Screener
8th Jun 20169:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
7th Jun 20162:26 pmRNSForm 8.3 - Cyprotex Plc
7th Jun 20168:57 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
6th Jun 20169:54 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
3rd Jun 20169:28 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
2nd Jun 20169:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.